ContraryTrader

Set alert and wait. Nvax pennant

Long
NASDAQ:NVAX   Novavax, Inc.
Forming a pennant on daily chart. Johnson &Johnson's misfortune still wasn't enough to push through. Channel resistance intersects with fib resistance at 204.
Public info says vaccine approval expected for UK and US use this quarter.

Entry 204 or pennant break out
targets (Green lines) are fib resistance

Related Ideas

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.